Skip to main content
Signal8
Bellon Steven F. profile photo

Steven F. Bellon

CIK: 0001831749

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Foghorn Therapeutics Inc. logo
FHTX

Foghorn Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jan 30, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    300K shares at avg. $5.71-
  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Jan 22, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    140K shares at avg. $4.37-
  • Foghorn Therapeutics Inc. logo
    FHTX

    Foghorn Therapeutics Inc.

    Sep 9, 2024
    Sale(S)
    Direct
    20K shares at avg. $9.50$190K

1-3 of 3

About Bellon Steven F.

Bellon Steven F. (SEC CIK 0001831749) files insider reports with the SEC as Chief Scientific Officer of Foghorn Therapeutics Inc. (FHTX).

Signal8 holds 3 ownership filings by Bellon Steven F., all Form 4s, filed between Sep 11, 2024 and Feb 2, 2026. Those filings report 3 transactions, from Sep 9, 2024 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bellon Steven F.'s filings is in WATERTOWN, MA.

Recent filings by Bellon Steven F.

  • Jan 30, 2026: Grant or award of FHTX derivative securities (Form 4, code A).
  • Jan 22, 2025: Grant or award of FHTX derivative securities (Form 4, code A).
  • Sep 9, 2024: Open-market sale of FHTX shares (Form 4, code S).

Other insiders filing for Foghorn Therapeutics Inc. (FHTX)

How to read Form 4 transaction codes